Abacavir Sulfate CAS Number 188062-50-2

Abacavir sulfate, chemically defined as chemical identifier 188062-50-2, acts as a highly effective HIV medication. It suppresses the replication of the human immunodeficiency virus (HIV) by interfering with the viral enzyme reverse transcriptase. This enzyme is crucial in the HIV life cycle, facilitating the virus to insert its genetic material in

read more

Pharmacological Properties of Abacavir Sulfate (188062-50-2)

Abacavir sulfate acts as a nucleoside reverse transcriptase inhibitor utilized in the management of human immunodeficiency virus infection. Its mechanistic properties rely on the potent inhibition of reverse transcriptase, an enzyme essential for HIV replication. Abacavir sulfate is a pro-drug that experiences conversion to its active form, carbov

read more

Leading API Manufacturer & Supplier

In today's rapidly evolving technological landscape, reliable and high-performance APIs are essential for organizations of all sizes. Top-rated global API manufacturer and supplier offers a comprehensive range of cutting-edge APIs designed to meet the diverse needs of modern applications. With a proven commitment to quality, innovation, and custome

read more

Pharmacological Properties of Abacavir Sulfate (188062-50-2)

Abacavir sulfate is a nucleotide reverse transcriptase inhibitor. Its mechanism of action involves the competitive suppression of HIV-1 reverse transcriptase, an enzyme crucial for viral replication. Abacavir sulfate exerts its effects by being incorporated into the growing DNA chain during reverse transcription, leading to premature stopping. This

read more

India's Premier Nutraceutical API Supplier

India has firmly established itself as a global hub for dietary supplement ingredient production, particularly in the realm of Active Pharmaceutical Ingredients (active ingredients). Numerous Indian firms specialize in the custom synthesis of nutraceutical active ingredients, serving both the national market and exporting globally. These companies

read more